A benign lesion is a growth or patch of abnormal tissue that stays where it started and doesn’t invade nearby tissue or spread, which is what separates it from cancer. For the large majority of people told their finding is benign, it will never become cancer. A handful of benign types, though, sit on a path toward cancer rather than off it, and that is why doctors sometimes remove or watch a growth that isn’t cancer.
Most Benign Growths Stay Benign
Moles show how low the odds usually are. The yearly chance that any one mole turns into melanoma is under 1 in 200,000 for people younger than 40.1PubMed Central. Dysplastic Nevi and Melanoma It rises with age but stays small, about 1 in 33,000 per year for men over 60.1PubMed Central. Dysplastic Nevi and Melanoma For a 20-year-old, the chance that a given mole becomes melanoma by age 80 is about 0.03% for men and 0.009% for women.1PubMed Central. Dysplastic Nevi and Melanoma Most moles stay stable for life, and common moles tend to fade in number with age.2PubMed Central. The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors3PubMed Central. Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression
Most melanomas arise in normal-looking skin rather than out of an existing mole.1PubMed Central. Dysplastic Nevi and Melanoma Having many moles still matters, but mainly as a sign that your skin is more prone to melanoma overall, not because each mole is a ticking clock.
When a mole does change, the cause is usually harmless. Irritation, rubbing from clothing, a small injury, or a harmless cyst forming can make a mole look different. Still, a mole that is bleeding, itching, or has changed over weeks to months deserves an exam, even though the likeliest explanation is benign. A doctor can often settle the question by looking through a magnifying skin scope, and may remove the mole to examine it if it still looks uncertain.
The words on a report can be confusing, so it helps to know what they mean. A lesion is any area of abnormal tissue, including spots, lumps and shadows on a scan. A tumor just means a mass, and it can be benign or malignant, which is the medical word for cancer. Benign describes how a growth behaves, not how big it is.
The Microscope Word That Matters Most, Atypia or Dysplasia
Your biopsy report may say “dysplasia” or “atypia.” Both mean the cells look abnormal under the microscope but haven’t invaded the surrounding tissue. In the mouth and throat, dysplasia is graded mild, moderate or severe, and it sits between harmless thickening and carcinoma in situ, which is cancer confined to the surface layer.4PubMed Central. Dysplasia of the Upper Aerodigestive Tract Squamous Epithelium In the airway, a smoker’s lining changes step by step, from overgrowth to an altered cell type to abnormal-looking cells, during long-term irritation.5PubMed. Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression
Breast findings show how these cell changes shift risk. Biopsies without overgrowth of cells raise future breast cancer risk only slightly, about 1.3 times average.6PubMed. Benign breast disease and the risk of breast cancer Overgrowth without abnormal cells roughly doubles risk compared with the general population.7JAMA Surgery. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era Atypical hyperplasia raises risk about 3 to 4 times.6PubMed. Benign breast disease and the risk of breast cancer7JAMA Surgery. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era That is why the word “atypical” on a breast report usually leads to closer screening even though it isn’t cancer.
A risk four times higher still means most women with atypia never get breast cancer. The risk applies to the whole breast, not only the biopsied spot.
Pathologists look at pattern as well as cell shape. In skin, cancerous growths tend to show widespread abnormal cells that spread sideways, while benign ones show scattered, limited changes.8PubMed. Pagetoid melanocytosis. Histologic features in benign and malignant lesions Some benign tumors can also contain areas that behave like cancer, with crowded, fast-dividing cells.9PubMed. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites
When you read your report, look for words like atypia, dysplasia, low-grade or high-grade. Higher grades mean more abnormal cells and more need for treatment, and your doctor can tell you what a grade means for your specific organ. For a borderline result, a second pathology opinion is reasonable.
Grade describes how different the cells look from normal ones, not how large the growth is. A tiny patch of high-grade change can matter more than a large patch of low-grade change.
Colon Polyps, The Clearest Path From Benign to Cancer
Adenomas are polyps made of gland cells that can grow, become more abnormal and eventually invade.10PubMed Central. Pathways of Colorectal Carcinogenesis Each step comes with another genetic change in genes that control growth.10PubMed Central. Pathways of Colorectal Carcinogenesis Not all adenomas become cancer, since the right changes must build up in the right order.10PubMed Central. Pathways of Colorectal Carcinogenesis
The timeline is usually long. The most common route to colon cancer can take 10 years or more.10PubMed Central. Pathways of Colorectal Carcinogenesis A faster route, seen in the inherited condition Lynch syndrome, can take only a few years.11PubMed. The American College of Gastroenterology Emily Couric Lecture–the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived?10PubMed Central. Pathways of Colorectal Carcinogenesis Size matters too: larger polyps progress faster, with estimates of about 26 years for tiny adenomas versus about 5 years for large ones.12PubMed Central. A case–cohort study for the disease natural history of adenoma–carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy Villous adenomas, a shape your report may name, progress faster than tubular ones, roughly 4 years versus 26.12PubMed Central. A case–cohort study for the disease natural history of adenoma–carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy
Taking out a polyp removes it before it can collect more changes, which is how colonoscopy prevents cancer. Your report’s polyp size, number and type set your next colonoscopy date.
The types on your report matter. Hyperplastic polyps, often small and in the lower colon, are usually harmless and don’t raise cancer risk much. Adenomas, including tubular and villous types, are the classic precancerous polyps. Sessile serrated polyps are another group with cancer potential and are followed up like adenomas, even though they can be flat and harder to see.
If a polyp is found during the exam, the doctor can usually remove it on the spot with a small wire loop passed through the scope, so most people need no separate surgery. The removed tissue goes to a pathologist, and the report that comes back days later decides your follow-up.
Other Benign Growths With Some Cancer Potential
About 20% of melanomas arise from an atypical mole.1PubMed Central. Dysplastic Nevi and Melanoma Even so, any single atypical mole rarely becomes melanoma, about 1 in 30,000 to 40,000 per year.1PubMed Central. Dysplastic Nevi and Melanoma Most atypical moles stay the same or fade over years of follow-up.1PubMed Central. Dysplastic Nevi and Melanoma Having one is a reason for a skin plan, not alarm. Doctors often photograph atypical moles or map the skin so later changes can be compared against a baseline. Some are removed if they look worrying or are hard to follow, and others are simply checked at regular visits. Several atypical moles, or relatives with melanoma, usually lead to more frequent full-skin checks.
To spot a changing mole, watch for asymmetry, irregular borders, a mix of colors, growth, or any other change. A spot that looks unlike your other moles deserves checking.
Liver adenomas depend on their subtype. One subtype, marked by a beta-catenin change, is linked to cancer.13PubMed. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation Another turns cancerous exceptionally rarely.14PubMed. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon So doctors may test a liver adenoma’s type to decide whether to remove it. These adenomas are often linked to birth control pills, so doctors may advise stopping estrogen, and large ones may be removed because of bleeding risk.
Cervical changes that last are tied to HPV infection that persists, especially at high levels.15PubMed. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia Progression to cancer involves the virus inserting itself into the cell’s DNA.16PubMed. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer HPV16 lesions are less likely to clear on their own.17Clinical Cancer Research. Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
Fibroids are different. Their genetic changes differ from those of a rare uterine cancer, so the typical fibroid change alone isn’t enough for cancer.18PubMed Central. Uterine Fibroids
Why Benign Growths Usually Stay Put
Benign growths carry real genetic mutations.19PubMed. Recurrent driver mutations in benign tumors A mutation is a change in a gene, and some changes push a cell to divide more than it should. One such change can create a growth, but turning cancerous usually needs further genetic or chemical changes to DNA.20PubMed Central. The Conundrum of Genetic “Drivers” in Benign Conditions In moles, benign ones carry a single BRAF change while melanomas gather several more, in steps.21PubMed. The Genetic Evolution of Melanoma from Precursor Lesions Cancer typically needs several safeguards to fail one after another.
Cells also put on the brakes. When a growth gene switches on, cells can enter a permanent resting state that halts growth.22PubMed. Many roads lead to oncogene-induced senescence This acts as a built-in safety switch keeping growths benign.23PubMed. Oncogene-induced senescence: putting the brakes on tumor development The surrounding tissue can also help hold growth back or let it progress.24PubMed Central. Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer
Cells can detect damaged DNA and either repair it or trigger their own self-destruction. A gene called p53 plays a major role in this, and cancers commonly have it disabled. While these backups still work, a cell with a growth-promoting mutation is often removed or held in check.
Some Precancerous Changes Go Away on Their Own
Regression is common at lower grades. In the airway, about 59% of severe dysplasia regressed without treatment.25PubMed Central. Natural history of bronchial preinvasive lesions Only 13% of cancer-in-situ lesions there regressed.25PubMed Central. Natural history of bronchial preinvasive lesions Mild and moderate dysplasia regress more often still.25PubMed Central. Natural history of bronchial preinvasive lesions
The immune system seems to help. Cervical lesions that clear show falling HPV levels.17Clinical Cancer Research. Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype Some breast precancers regress at menopause.26PubMed. Premalignant breast lesions: role for biological markers in predicting progression to cancer
Doctors still follow lesions that may regress because you can’t tell in advance which ones will clear. Repeat tests show the direction of change, and quitting smoking helps the airway lining recover. A normal result after an abnormal one is good news but doesn’t always end follow-up right away.
Watch, Biopsy or Remove, What Follow-Up Looks Like
With active surveillance, doctors watch with repeat scans instead of operating. Benign breast papillomas found on needle biopsy can be safely watched with imaging.27PubMed. Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance Benign kidney oncocytomas are often watched too, with treatment usually prompted by growth of about 5 mm a year.28PubMed Central. Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis Because these can grow at rates similar to cancers, growth alone can lead to unnecessary surgery.28PubMed Central. Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis
Thyroid nodules are scored on ultrasound to decide whether they need biopsy.29PubMed. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment Most are benign, and features such as shape, edges and internal pattern indicate how suspicious a nodule is. Only nodules above a certain risk and size usually get a fine needle sample, done in the office with a thin needle. Unclear biopsies may get molecular tests or a second opinion,29PubMed. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment while a benign result often leads to repeat ultrasound later rather than surgery.
Treating harmless growths can bring stress, surgical complications and organ damage,30PubMed. The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review so watching is often the safer choice. Doctors weigh the growth’s type, size, how fast it changes, and whether the cells look abnormal on biopsy. Your age, other health problems, and the risks of the procedure also matter. If a lesion looks stable and low risk, watching is reasonable, and a clear change can then prompt removal.
In practice, repeat scans often come at 6 to 12 months first, and the intervals lengthen if the growth is stable. Keep copies of your reports so later results can be compared with them.
Useful questions for your doctor: What type is it exactly, and does it carry any cancer risk? Is there atypia or dysplasia? When is my next check, and with what test? What change would lead to removal?
Incidental Findings on Scans
Accidental findings are common. Over a third of heart MRIs and some chest CTs find something unexpected,31PubMed Central. Prevalence and outcomes of incidental imaging findings: umbrella review and spine and brain MRIs find something in about 22%.31PubMed Central. Prevalence and outcomes of incidental imaging findings: umbrella review Many such findings are cysts, scars, or normal variations. Finding one doesn’t mean something is wrong with you.
The odds of cancer vary by organ. Fewer than 5% of accidental brain or adrenal findings are cancer.31PubMed Central. Prevalence and outcomes of incidental imaging findings: umbrella review About 80% of adrenal findings are harmless, non-hormone-making adenomas.32Australian Family Physician. Incidental adrenal masses – A primary care approach About a quarter of kidney, thyroid and ovary findings are cancer,31PubMed Central. Prevalence and outcomes of incidental imaging findings: umbrella review and breast findings are cancer about 42% of the time.31PubMed Central. Prevalence and outcomes of incidental imaging findings: umbrella review
Radiologists describe features such as size, shape, edges and fluid content, and many classic benign appearances need no further testing. Findings that look uncertain are usually checked with a repeat scan after a set interval, a different imaging test, or a biopsy. Guidelines for specific findings, like adrenal or thyroid nodules, set when follow-up is needed.
After an accidental finding, ask whether follow-up imaging or a hormone test is needed, and don’t ignore the recommendation letter.

